key: cord-0859598-vyomj8y5 authors: Xu, Yingyang; Guan, Kai title: Real‐life data on inactivated COVID‐19 vaccination in patients with subcutaneous allergen immunotherapy date: 2022-01-20 journal: Clin Transl Allergy DOI: 10.1002/clt2.12115 sha: 4e859cfa888b2bf286fad4f33aef885e8fb27ad5 doc_id: 859598 cord_uid: vyomj8y5 nan To the Editor, Allergen-specific immunotherapy (AIT) is an important therapeutic option for allergic diseases mediated by IgE. Subcutaneous immunotherapy (SCIT) requires patients to regularly visit their doctors and receive injections at weekly or monthly intervals for at least 3 years. However, the ongoing COVID-19 pandemic has influenced the routine for SCIT and impacted adherence to SCIT to a large degree. 1, 2 Vaccination is considered as an effective strategy to prevent COVID-19 pandemic and allergen immunotherapy-an EAACI survey Senses Dinc G, Dibek Misirlioglu E. Effect of patient and parental anxiety on adherence to subcutaneous allergen immunotherapy during the coronavirus disease 2019 pandemic Standards for practical allergen-specific immunotherapy COVID-19 vaccination and allergen immunotherapy (AIT)-a position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI) Allergen immunotherapy management during vaccinations: an international survey Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism. Vaccines (Basel) Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types Vaccination during concurrent subcutaneous immunotherapy: safety of simultaneous application None of the authors has potential conflict of interest related to this manuscript. Yingyang Xu has made substantial contributions to design of the study, acquisition of data, analysis and interpretation of data, and drafting the article. Kai Guan has made substantial contributions to design of the study, acquisition of data, and giving final approval of the version to be submitted.